NFKB1 and rheumatoid arthritis: TQ was reported to downregulate pro-inflammatory genes such as IL-1, TNF-α, and toll-like receptors (TLR2, TLR4) and attenuate rheumatoid arthritis via the NFkB pathway (Arjumand et al., 2019).